Remdesivir close to EU's initial authorisation as COVID-19 treatment

By Administrator_India Capital Sands The head of the European Union’s medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead’s remdesivir as a COVID-19 treatment could be granted in coming days. The European Medicines Agency  has already recommended the compassionate use of remdesivir, which allowsContinue Reading